Navigation Links
Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
Date:6/18/2008

0:

1) Predicting response to treatment of ovarian cancer patients

- Platinum-based cytotoxic chemotherapy in conjunction with debulking surgery is currently the gold standard of treatment for patients with ovarian cancer. However, approximately 20-50% of patients do not respond to platinum-based chemotherapy and will require additional second line treatment. Furthermore, research suggests that administering platinum-based treatment to patients who subsequently do not respond to it may actually hinder their response to the second line treatment as well. Rosetta Genomics has identified unique microRNA biomarkers that may assist in identifying ovarian cancer patients expected to benefit from platinum-based chemotherapy.

2) Predicting risk of gastric cancer recurrence - Recurrence after curative resection for gastric cancer is high and is estimated to occur in 50-80% of patients. This test will use microRNA molecular classification of gastric cancer samples to predict the risk of recurrence for non-metastatic patients after resection of the primary tumor.

3) Differentiating small from non-small cell lung cancer - An estimated 220,000(1) patients are diagnosed with lung cancer each year in the U.S. alone. Before a patient begins lung cancer treatment, an experienced lung cancer pathologist must review the pathologic material. This is critical because small cell lung cancer, which is generally not treated surgically, can be confused on microscopic examination with non-small cell carcinoma(2). Rosetta Genomics has identified unique microRNA biomarkers that may be used to differentiate small from non-small cell lung cancers.

In addition, utilizing its proprietary extraction and quantification microRNA technologies, the Company has recently identified microRNA biomarkers in the serum of colon cancer patients which may serve as the basis for a future blood-based test for colon cancer.

"Molecular diagnostic companies like Rosetta Genom
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...wire/ -- The Burrill Biotech Select Index managed ...ber. The Select,s gain of 4.5 percent mirrored wha...ets with the Dow up 6.5 percent and the NASDAQ up ...inal two trading days of the month despite investo...ping and Dubai,s reported debt woes. ,, Almost ...
(Date:12/1/2009)...day announced a collaborative research agreement w...aluating EpiVax’s proprietary Tregitope tech... immune responses to certain drugs. In the course ...itope technology will be evaluated for its effect ..., (Vocus) December 2, 2009...
(Date:12/1/2009)...swire-FirstCall/ -- Palatin Technologies, Inc. (NY...nt and Trademark Office has issued U.S. Patent No....structs." The claims in the issued patent cover a...ic peptide receptor A (NPRA), including PL-3994, P..."Our natriuretic compounds, including PL-3994, add...
(Date:12/1/2009)...lifornia and AMSTERDAM, December 1 ...ostics, announced today that,Palmetto GBA, Califor...ed,coding guidelines for the company,s MammaPrint ...ancer recurrence test, which has been reimbursed b...e United States can now submit claims for the,Mamm...
Breaking Biology Technology:Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...ALGARY, March 10 /PRNewswire-FirstCall/ - Dr. Brad... Inc. (TSX: ONC, NASDAQ: ONCY), will present a,cor...08 Conference on,Thursday, March 13, 2008. The eve...Switzerland from March 12-14, 2008., About Oncoly...biotechnology company focused on the,development o...
...onogram Assays to be used by Avexa to select patie... in phase III program, SOUTH SAN FRANCISCO, Calif... MGRM ) announced today that the Company,has signe... the exclusive,provider of HIV resistance and trop...discovery and development programs., Avexa plans ...
...ALO ALTO, Calif., March 10 Varian, Inc.,(Nasdaq: ...d Probe. Designed,for use with the Varian NMR Syst... for 13C detected NMR experiments., The XSens Pro...ts for,researchers in pharmaceutical, agricultural...he characterization of quantity-limited samples,of...
Other Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008 2Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 2Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 3Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 4Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 5New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments 2
(Date:12/1/2009)... The Georgia Institute of Technology has been awa...gn nanostructures for energy harvesting and adapti...tical cognitive processes of the modern warfighter...nano-enabled Inorganic/Organic Nanostructures and ...y Vladimir Tsukruk and Kenneth Sandhage, professor...
(Date:12/1/2009)...GAINESVILLE, Fla. Hit-and-run attacks by sharks c...the culprits by the unique chomp they put on their...earcher and shark expert. , In a method analogou...make identifications by precisely comparing shark ...ors, said George Burgess, director of the Internat...
(Date:12/1/2009)... , RICHLAND, Wash. -- Time-lapsed video of indivi...en event in the life of a cell: a protein that cyc...e results give researchers a more complete view of...ls to grow, events that go awry in cancer and are ... which helps cells respond to growth factors, trav...
Breaking Biology News(10 mins):Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 1Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 1Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 3Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 4PATHFAST 28R 29 Rapid Whole Blood Immunoassay Analyzer from Polymedco 49913 1PATHFAST 28R 29 Rapid Whole Blood Immunoassay Analyzer from Polymedco 49913 2
... May 15, 2008 (BRONX, NY) Contrary to long-held ...risk of death, according to investigators from the...iversity. They reached their conclusion after exam...tive sample of adults in the U.S. The Einstein res...ed risk of death from cardiovascular disease (CVD)...
... COLLEGE STATION A large quantity of nitrogen com...gh the burning of fossil fuels and the use of nitr... the removal of some carbon dioxide from the atmos...s led by Texas A&M University Distinguished Profes...t Duce. , The team of 30 experts from institution...
... LA JOLLA, CA - Now that high school biology stude...s transcribed into messenger RNA (mRNA), which is ...ass of molecules, sending studentsand many scienti... Salk Institute for Biological Studies investigato...8 online issue of Developmental Cell, shows that t...
Other Biology News:New study casts further doubt on risk of death from higher salt intake 2Atmosphere threatened by pollutants entering ocean, prof says 2Atmosphere threatened by pollutants entering ocean, prof says 3Plant biologists discover unexpected proteins affecting small RNAs 2Plant biologists discover unexpected proteins affecting small RNAs 3
Human Granzyme B ELISPOT Kit from DiaPharma Group, Inc.
Rat Caspase-3 Active from BioVision
Mouse Anti-Rat KAPPA / LAMBDA Monoclonal Antibody, Horseradish Peroxidase Conjugated, Clone MARK-1 / MARL-15 from Cell Sciences
MagCellect Rat CD4+ T Cell Isolation Kit from R&D Systems
Biology Products: